The Valley Desk

NCT04639310 · Interventional trial

XEN496 (Ezogabine) in Children With KCNQ2 Developmental and Epileptic Encephalopathy

Overall registry status Terminated

Phase 3

Conditions Brain Diseases, Central Nervous System Diseases, Disease, Epilepsy, Epilepsy in Children, Epilepsy; Seizure, Epileptic Syndromes, Nervous System Diseases

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov